During Monday’s trading session, the shares of a research-based Global Pharmaceutical and Biotech company surged nearly 4 percent to Rs. 1,441.95, after its antibiotic drug ‘Zaynich’ achieved 97 percent effectiveness in treating severe pneumonia infections.  With a market capitalisation of Rs. 22,745 crores, at 12:30 p.m., the shares of Wockhardt Limited were trading in the … Continue reading Pharma stock jumps 4% after its drug achieved 97% efficacy in treating Pneumonia infections